全文获取类型
收费全文 | 132297篇 |
免费 | 12620篇 |
国内免费 | 8994篇 |
专业分类
耳鼻咽喉 | 1175篇 |
儿科学 | 1563篇 |
妇产科学 | 1663篇 |
基础医学 | 14422篇 |
口腔科学 | 2384篇 |
临床医学 | 16487篇 |
内科学 | 18555篇 |
皮肤病学 | 1292篇 |
神经病学 | 6787篇 |
特种医学 | 4917篇 |
外国民族医学 | 56篇 |
外科学 | 13644篇 |
综合类 | 24914篇 |
现状与发展 | 28篇 |
一般理论 | 15篇 |
预防医学 | 9979篇 |
眼科学 | 3220篇 |
药学 | 14344篇 |
135篇 | |
中国医学 | 7714篇 |
肿瘤学 | 10617篇 |
出版年
2024年 | 525篇 |
2023年 | 2080篇 |
2022年 | 5389篇 |
2021年 | 6606篇 |
2020年 | 5036篇 |
2019年 | 4017篇 |
2018年 | 4429篇 |
2017年 | 4231篇 |
2016年 | 3892篇 |
2015年 | 6072篇 |
2014年 | 7476篇 |
2013年 | 7273篇 |
2012年 | 10770篇 |
2011年 | 11515篇 |
2010年 | 7940篇 |
2009年 | 6426篇 |
2008年 | 7963篇 |
2007年 | 7653篇 |
2006年 | 6901篇 |
2005年 | 6488篇 |
2004年 | 4483篇 |
2003年 | 3915篇 |
2002年 | 3329篇 |
2001年 | 2688篇 |
2000年 | 2646篇 |
1999年 | 2595篇 |
1998年 | 1636篇 |
1997年 | 1602篇 |
1996年 | 1225篇 |
1995年 | 1196篇 |
1994年 | 929篇 |
1993年 | 613篇 |
1992年 | 694篇 |
1991年 | 645篇 |
1990年 | 543篇 |
1989年 | 454篇 |
1988年 | 387篇 |
1987年 | 382篇 |
1986年 | 292篇 |
1985年 | 229篇 |
1984年 | 155篇 |
1983年 | 96篇 |
1982年 | 75篇 |
1981年 | 59篇 |
1980年 | 38篇 |
1979年 | 59篇 |
1978年 | 27篇 |
1974年 | 27篇 |
1973年 | 19篇 |
1972年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Raquel Carreira Ana Duarte Pedro Monteiro Maria Sancha Santos Ana Cristina Rego Catarina R Oliveira Lino M Gon?alves Luís A Providência 《Revista portuguesa de cardiologia》2004,23(11):1447-1455
Ischemia negatively affects mitochondrial function by inducing the mitochondrial permeability transition (MPT). The MPT is triggered by oxidative stress, which occurs in mitochondria during ischemia as a result of diminished antioxidant defenses and increased reactive oxygen species production. It causes mitochondrial dysfunction and can ultimately lead to cell death. Therefore, drugs able to minimize mitochondrial damage induced by ischemia may prove to be clinically effective. We analyzed the effect of carvedilol, a beta-blocker with antioxidant properties, on mitochondrial dysfunction. Carvedilol decreased levels of TBARS (thiobarbituric acid reactive substances), an indicator of oxidative stress, which is consistent with its antioxidant properties. Regarding cell death by apoptosis, although ischemia did increase caspase-8-like activity, there were no changes in caspase-3-like activity, which is activated downstream of caspase-8; this may indicate that the apoptotic cascade is not activated by 60 minutes of ischemia. We conclude that carvedilol protects ischemic mitochondria by preventing oxidative mitochondrial damage, and, by so doing, it may also inhibit the formation of the MPT pore. 相似文献
92.
93.
S Lu D D Parekh O Kuznetsova S A Green C A Tozzi T F Reiss 《The European respiratory journal》2006,28(4):772-780
Cholinergic antagonists have been used since the early 1900s as bronchodilators for chronic obstructive pulmonary disease (COPD). The present study investigated whether an oral muscarinic M3-selective anticholinergic agent (OrM3) would provide an improved therapeutic advantage compared with an inhaled anticholinergic agent in patients with COPD. A 6-week, multicentre, randomised, placebo- and active-controlled, parallel-group study was performed at 56 sites in the USA. In total, 412 male and female patients (aged 35-86 yrs) with a clinical history consistent with COPD were randomised to receive OrM3 0.5, 2, 3 or 4 mg orally once daily, ipratropium bromide 36 mug by inhalation four times daily or placebo. OrM3 demonstrated a significant dose-related improvement in serial forced expiratory volume in one second and a trend for dose-related improvement in patient-reported symptoms compared with placebo. However, at a dose that provided efficacy less than that of ipratropium, the incidence of dose-related, mechanism-based side-effects for OrM3 exceeded those observed for ipratropium. In patients with chronic obstructive pulmonary disease, the oral M3-selective agent did not offer a therapeutic advantage over inhaled ipratropium. These results do not support the hypothesis that high selectivity for muscarinic M3 receptors over airway neuronal M2 receptors will represent a more effective therapy than current inhaled anticholinergics in obstructive airway disease. 相似文献
94.
Yan Wang Xuesong Zhang Songhua Xiao Ning Lu Zheng Wang Mi Zhou 《Journal of orthopaedic surgery and research》2006,1(1):13-7
Objectives
To investigate clinical effects and manual operational point of Bryan cervical disc prosthesis in Chinese, to observe the stability and range of movement (ROM) post-operatively. 相似文献95.
BACKGROUND: Dietary salt and fluid restriction is important in controlling fluid balance in patients on continuous ambulatory peritoneal dialysis (CAPD). However, it is often difficult to monitor patients' dietary total sodium intake (TSI). Usually, total sodium removal (TSR), the sum of urinary sodium removal (USR) and dialysate sodium removal (DSR), is suggested to represent TSI. In the present study, we investigated the reliability of using TSR as a surrogate to TSI in CAPD patients. METHODS: 40 clinically stable CAPD patients were closely followed for 3 months. Their TSI, USR, DSR, and fluid status were measured twice: at baseline and at the end of this study respectively. Fluid status was evaluated by bioimpedance analysis. Patients with increased sodium intake (group ISI) or decreased sodium intake (group DSI) (both >0.5 g/day or >21.74 mmol/day elemental sodium) were included in this study. RESULTS: There were 15 patients in group ISI and 9 patients in group DSI. During the follow-up, although TSI increased in group ISI and decreased in group DSI (p < 0.05), there were no significant changes in USR, DSR, or TSR in either group. No relationship was found between TSI and TSR. Changes in weight, blood pressure, urine volume, ultra-filtration, and small solute removal (Kt/V and creatinine clearance) were not statistically significant between the two groups. Fluid status deteriorated in group ISI and improved in group DSI (p < 0.05). CONCLUSIONS: Our study suggests that changes in total sodium intake do not lead to proportionate changes in total sodium removal in CAPD patients. Therefore, TSR (the sum of USR and DSR) should be used cautiously to monitor TSI in this patient population. 相似文献
96.
In this survey, 60 patients with pulmonary infection (mainly nosocimial pneumonia) were divided into two groups randomly. 30 patients treated by injection of Scutelleria compound and 30 patients by intravenous piperacillin sodium as control. Before treatment there was no significant difference of clinical data between two groups. The total efficacy was evaluated after treatment for one week. 40%, 36.7% were marked effective in corresponding. 33.3%, 40% were effective and 26.7%, 23% were ineffective respectively. Total effective rates were 73.3% and 76.7% in corresponding group. Temperature was average decreased for 7.43 +/- 3.02 and 7.63 +/- 5.79 days, symptoms disappeared or relieved for 11.67 +/- 6.75 days and 11.53 +/- 7.30 days, leucocyte decreased to normal on 9.03 +/- 6.53 days and 10.13 +/- 6.23 days, roentgenographical shadows disappeared or became smaller for 16.1 +/- 7.02 days and 16.1 +/- 9.88 days in corresponding group. There were no side-effect of the functions of liver, kidney and medulla ossium in two groups. In piperacillin sodium group, fungal infection were found in 4 of 30 patients, but there was no any case suffered from fungal infection in injection of Scutelleria compound group. It was suggested that injection on Scutelleria compound is a hopeful preparation and should be studied further. 相似文献
97.
98.
99.
豚鼠中耳(听泡)内滴入0.5%、1%、2%环丙沙星与庆大霉素滴耳液7天或21天,借助光镜和扫描电镜观察内耳的显微和超微结构变化。结果证明环丙沙星对内耳没有明显的毒性作用。庆大霉素则使耳蜗明显受损,以底回为重,Corti’s器外毛细胞坏死较多,内毛细胞及支持细胞病变较轻。位觉斑耳石脱落,毛细胞纤毛粘连、脱落。壶腹嵴中央区纤毛也缺失。本实验对客观评价环丙沙星对内耳的作用及临床使用提供了形态学资料。 相似文献
100.
Seventy-three patients with portal hypertension who underwent Hassab operation before June 30, 1976 and were alive postoperatively were analysed. Among these patients, portal hypertension was caused by hepatic schistosomiasis in fifty-seven, and by portal cirrhosis in seventeen. According to Child's classification there were 14 in class A, 19 in class B, 30 in class C, and 10 were not classified. Thirty-two patients were subjected to therapeutic operation, forty-one to prophylactic operation. Seventy-one patients were followed-up (97.3%). The postoperative 5, 10 and 15 year cumulative survival rate were 85.5%, 75.8%, and 70.4% respectively. The survival rates in Child A, B patients were much higher than that in Child C patients (P less than 0.05). The postoperative bleeding rate was 11.3%, and the bleeding most often occurred in 1-9 year postoperatively. The esophageal varices disappeared in 64.3% of patients; ascites disappeared in 91.7% of patients; liver function improving or unchanging was seen in 93.6% of patients. There was no postoperative encephalopathy. Long term follow-up showed no difference in patient's survival rate between hepatic schistosomiasis and portal cirrhosis. 相似文献